Acute coronary syndrome secondary to paradoxical bronchospasm due to nebulized ipratropium bromide
نویسندگان
چکیده
منابع مشابه
Acute coronary syndrome secondary to paradoxical bronchospasm due to nebulized ipratropium bromide
Ipratropium bromide is a muscarinic receptor antagonist used worldwide for management of chronic obstructive pulmonary disease (COPD) and acute asthma. It is considered a safe drug. Most common anticholinergic adverse effects are dry mouth, constipation and urinary retention. Cardiac and respiratory disorders are considered rare. We report a case of acute coronary syndrome secondary to its use....
متن کاملEffect of nebulized ipratropium bromide on intraocular pressures in children.
STUDY OBJECTIVE To evaluate the effects of nebulized ipratropium bromide on intraocular pressures and pupillary responses in children with asthma. DESIGN A double-blind, randomized, crossover study. SETTING Children's Hospital of Winnipeg, University of Manitoba. PATIENTS OR PARTICIPANTS Age 6 to 17 years with asthma. INTERVENTION Nebulized ipratropium bromide added to albuterol sulfate...
متن کاملTransient anisocoria in a patient treated with nebulized ipratropium bromide
Purpose We present a case report of a 44-year old female patient with complicated pneumonia who developed anisocoria after treatment with inhaled ipratropium bromide. Discontinuation of ipratropium bromide treatment led to complete resolution of anisocoria. Observation A 44-year old female patient was admitted to the Department of Pulmonology due to high body temperature (40.0 °C), coughing a...
متن کاملIpratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma.
OBJECTIVE To determine whether the addition of repeated doses of nebulized ipratropium bromide (IB) to a standardized inpatient asthma care algorithm (ACA) for children with status asthmaticus improves clinical outcome. STUDY DESIGN Children with acute asthma (N = 210) age 1 to 18 years admitted to the ACA were assigned to the intervention or placebo group in randomized double-blind fashion. ...
متن کاملIpratropium Bromide plus Nebulized Albuterol for the Treatment of Hospitalized Children with Acute Asthma
were also statistically significant differences in asthma symptom scores and number of puffs of rescue medication in favor of omalizumab. Incidence of adverse effects were similar in placebo and omalizumab groups. Conclusion. These results indicate that omalizumab therapy safely improves asthma control in allergic asthmatics who remain symptomatic despite regular use of inhaled corticosteroids ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Case Reports and Reviews
سال: 2017
ISSN: 2059-0393
DOI: 10.15761/ccrr.1000330